DrugPatentWatch Database Preview
Ardelyx Inc Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for ARDELYX INC, and what generic alternatives to ARDELYX INC drugs are available?
ARDELYX INC has one approved drug.
There are four US patents protecting ARDELYX INC drugs.
There are twenty-eight patent family members on ARDELYX INC drugs in twenty-one countries.
Drugs and US Patents for Ardelyx Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ardelyx Inc | IBSRELA | tenapanor hydrochloride | TABLET;ORAL | 211801-001 | Sep 12, 2019 | RX | Yes | Yes | 8,541,448 | Start Trial | Y | Y | Start Trial | ||
Ardelyx Inc | IBSRELA | tenapanor hydrochloride | TABLET;ORAL | 211801-001 | Sep 12, 2019 | RX | Yes | Yes | 9,006,281 | Start Trial | Start Trial | ||||
Ardelyx Inc | IBSRELA | tenapanor hydrochloride | TABLET;ORAL | 211801-001 | Sep 12, 2019 | RX | Yes | Yes | 9,408,840 | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Ardelyx Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Mexico | 2011007024 | Start Trial |
Portugal | 2384318 | Start Trial |
World Intellectual Property Organization (WIPO) | 2018129556 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.